The vaccine is based on a modified human adenovirus, is administered in a single dose and is recommended by the WHO for all age groups from 18 years of age, according to a WHO statement.
Chinese vaccine anticovid Convidecia receives emergency approval from the WHO. Photo: Illustrative
The World Health Organization on Thursday announced the emergency approval of Chinese company CanSino Biologics’ Convidencia vaccine, as Beijing battles a resurgent Covid pandemic.
The vaccine is based on a modified human adenovirus, is administered in a single dose and is recommended by the WHO for all age groups from 18 years of age, according to a WHO statement.
Sending Data…
